Furthermore, to elucidate the impact of SLC25A22 expression, we stratified the 44 CSCC patients into a high‐ (n = 22) and a low‐SLC25A22 expression groups (n = 22) based on median expression levels. Here, SLC25A22 is linked to skin squamous cell carcinoma.